Abivax S.A.
ABVX NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
May 22, 2026
ET
EPS Est.
-1.07
EPS Actual
-0.71
Revenue Est.
$401125
Revenue Actual
$1.5M
Next Earnings Report Date unconfirmed
Date
Sep 21, 2026 · Mon
Time
Pre-market
Fiscal Period
FY2026 Q2
EPS Est.
-0.96
Revenue Est.
$778451
Company Overview
Abivax S.A. (ticker ABVX) is listed on NASDAQ with a market cap of about $8.44B. Its next earnings report (FY2026 Q2) is expected on Sep 21, 2026 (ET), Pre-market (date pending company confirmation), with consensus EPS of -0.96. In the last 11 reported quarters, EPS beat consensus estimates 4 times.
Actual EPS TrendRecently14Term · Sep 23, 2021 → May 22, 2026
Sep 23, 2021Range: -2.47 ~ -0.70May 22, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| May 22, 2026 | -- | -1.07 | Above forecast↑-0.71 | $401125 | $1.5M |
| Mar 23, 2026 | -- | -1.70 | Above forecast↑-1.19 | $1.8M | $515064 |
| Dec 15, 2025 | -- | -0.79 | Below forecast↓-2.47 | $1.3M | $2.4M |
| Sep 8, 2025 | -- | -0.90 | -0.86 | $1.3M | $1.3M |
| Jun 2, 2025 | -- | -0.76 | Below forecast↓-0.97 | $3.3M | $1.2M |
| Mar 24, 2025 | -- | -0.76 | Below forecast↓-1.68 | $2.8M | $6.4M |
| Nov 14, 2024 | -- | -0.72 | -0.70 | $3.6M | -- |
| Sep 9, 2024 | -- | -0.74 | Below forecast↓-1.44 | $3.8M | $7.2M |
| Apr 2, 2024 | -- | -0.91 | Below forecast↓-1.94 | $2.5M | $2.5M |
| Sep 21, 2023 | -- | -0.67 | Below forecast↓-1.55 | $1.2M | $2.5M |
| Apr 19, 2023 | -- | -1.93 | -- | $1.3M | -- |
| Dec 31, 2022 | -- | -1.93 | -1.95 | -- | $2.4M |
| Sep 15, 2022 | -- | -- | -1.84 | -- | $2.3M |
| Mar 16, 2022 | -- | -- | -1.68 | -- | -- |
| Sep 23, 2021 | -- | -- | -1.34 | -- | -- |
Original Filings (SEC)
6-K2026-07-02 ↗
6-K2026-06-29 ↗
6-K2026-06-02 ↗
6-K2026-05-22 ↗
6-K2026-05-20 ↗
6-K2026-05-07 ↗
6-K2026-04-20 ↗
20-F2026-03-23 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
